US.BSX · Boston Scientific

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.5,
      "details": {
        "atrPct": 4.285946952070731,
        "turnoverUsdM": 1159.11102972,
        "liquidityPoints": 0.8,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.BSX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 39.2958,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 8.6,
      "take_profit_price": 46.7133,
      "target_multiplier": 1.9,
      "technical_strength": 1.6,
      "take_profit_percent": 8.7
    },
    "positionPoints": 1.5,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 8.571893904141461,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 46.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 39.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 48.0775,
    "ma50": 46.9372,
    "close": 42.98,
    "prevClose": 43.1,
    "avgVolume20": 20429436,
    "volumeRatio": 1.32,
    "changePercent": -0.28
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": -0.08455804046858373,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.3575257833671137,
      "ret_points": 0,
      "vol_points": 4,
      "range_ratio": 0.49141423862571976,
      "volat_points": 0,
      "day_range_pct": 0.017449976733364358,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 46.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 94,
        "contribution": 4.7
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 5.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 37.33,
        "contribution": 5.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.1,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 61,
        "contribution": 6.1
      },
      {
        "raw": 11.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 39.67,
        "contribution": 11.9
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 39.5,
    "details": [
      "基本面分析總分: 4.7/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 5.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.1/10分",
      "技術信號分析總分: 11.9/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.7,
      "資金流": 5.2,
      "市場環境": 5.6,
      "情緒分析": 4,
      "技術信號": 11.9,
      "風險管理": 6.1
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.5,
          "epsPoints": 0.75,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 1159.11102972,
          "volumePoints": 0.5,
          "revenuePoints": 0.75,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.BSX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 715.6679992,
                "ma50": 710.4063990999997,
                "name": "QQQ",
                "close": 714.88,
                "points": 1.4
              },
              "spy": {
                "ma20": 766.87899445,
                "ma50": 758.61640102,
                "name": "SPY",
                "close": 764.28998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 4.285946952070731,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142089639,
                "url": "https://finnhub.io/api/news?id=52dcb991320eb9f86646423e59e8a9e76dd0d08c29cfb3f8b8de0fbf688cb333",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) trades at about $43, roughly 17% below the recent high it set on 19th Aug, 2026. Its own history with sharp drops is encouraging. That history does not cover a cyberattack it says is likely to hit its 2026 results, and the stock is down about 60% over the past twelve months. Start with the history.",
                "category": "company",
                "datetime": 1789152632,
                "headline": "Is This BSX Stock Pullback Worth The Patience?"
              },
              {
                "id": 142084867,
                "url": "https://finnhub.io/api/news?id=2cb61d503c9e91fcda692076a130be9879c2b818f7f462ab88c0702ddfd6b203",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
                "category": "company",
                "datetime": 1789133402,
                "headline": "Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?"
              },
              {
                "id": 142067348,
                "url": "https://finnhub.io/api/news?id=dfa5079fce0ec9563cc45107f80904136c80d2ce1641208fd37faf3f76361eb3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) reached $43.1 at the closing of the latest trading day, reflecting a -4.14% change compared to its last close.",
                "category": "company",
                "datetime": 1789077603,
                "headline": "Why Boston Scientific (BSX) Dipped More Than Broader Market Today"
              },
              {
                "id": 142062556,
                "url": "https://finnhub.io/api/news?id=6ffdbe05d27dc47b920fc89735b69b29a5e324c423a0a9938e918775d602e569",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "BSX",
                "summary": "Boston Scientific Corporation (BSX) Wells Fargo 21st Annual Healthcare Conference September 10, 2026 8:00 AM EDTCompany ParticipantsMichael Mahoney -...",
                "category": "company",
                "datetime": 1789043825,
                "headline": "Boston Scientific Corporation (BSX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 142028634,
                "url": "https://finnhub.io/api/news?id=80e7de8999e6a41acd61752ba4a09ba315b534d097c582121d26f62ef8d54a24",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak.  Instead of buying the dip outright, selling cash-secured put options allows investors to generate immediate income while locking in an even deeper entry point.  Sell a put option on BSX expiring 9/17/2027, with a strike price of $30.",
                "category": "company",
                "datetime": 1788977210,
                "headline": "BSX Stock: Is It Time To Buy Or Sell Puts?"
              },
              {
                "id": 141455029,
                "url": "https://finnhub.io/api/news?id=9980113490b89d23a66c8ffb6cd96ecfaacbd42b6a644618293f4755fb4708bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term ~6% growth leaves our 10.8% three-year CAGR reliant on a post-2026 pipeline re-acceleration.",
                "category": "company",
                "datetime": 1788546339,
                "headline": "How Much Upside Can BSX Stock's Growth Deliver?"
              },
              {
                "id": 141425819,
                "url": "https://finnhub.io/api/news?id=16e0a7c13c94a2bda9b72b3dce557a34e74dde795511a5550e58651cec3baa9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "In recent weeks, Boston Scientific has faced multiple voluntary global recalls of its Suture Cinch endoscopic devices and ENROUTE Transcarotid Neuroprotection systems, alongside a cybersecurity incident that disrupted operations and led to reduced full‑year 2026 sales and earnings guidance. These simultaneous product quality issues, operational disruptions, and softer demand for key franchises raise fresh questions about the resilience of Boston Scientific’s previously growth-focused...",
                "category": "company",
                "datetime": 1788513680,
                "headline": "Did Recalls And Cyberattack Disruptions Just Shift Boston Scientific's (BSX) Investment Narrative?"
              },
              {
                "id": 141406366,
                "url": "https://finnhub.io/api/news?id=ac7dcb864c0ad21643873e43ba99970b20ef847f2cfaba6231d7dd5dfc7cee5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "In the most recent trading session, Boston Scientific (BSX) closed at $46.95, indicating a -2.94% shift from the previous trading day.",
                "category": "company",
                "datetime": 1788472802,
                "headline": "Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors"
              }
            ],
            "raw_source": [
              {
                "id": 142089639,
                "url": "https://finnhub.io/api/news?id=52dcb991320eb9f86646423e59e8a9e76dd0d08c29cfb3f8b8de0fbf688cb333",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) trades at about $43, roughly 17% below the recent high it set on 19th Aug, 2026. Its own history with sharp drops is encouraging. That history does not cover a cyberattack it says is likely to hit its 2026 results, and the stock is down about 60% over the past twelve months. Start with the history.",
                "category": "company",
                "datetime": 1789152632,
                "headline": "Is This BSX Stock Pullback Worth The Patience?"
              },
              {
                "id": 142084867,
                "url": "https://finnhub.io/api/news?id=2cb61d503c9e91fcda692076a130be9879c2b818f7f462ab88c0702ddfd6b203",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
                "category": "company",
                "datetime": 1789133402,
                "headline": "Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?"
              },
              {
                "id": 142087247,
                "url": "https://finnhub.io/api/news?id=3530372a838cfeede74a1225919d8339dfe78b671158f3ecfb1f83596173ce73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "CEO Mike Mahoney gave more details at a Thursday investor conference, saying the company likely lost orders while its plants and distribution centers were shut down.",
                "category": "company",
                "datetime": 1789127820,
                "headline": "Boston Scientific fully restores operations after cyberattack"
              },
              {
                "id": 142086693,
                "url": "https://finnhub.io/api/news?id=8487cdc595b23baf9231030f412db6f9f197b2603e410c71f10918068e2bac4c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1472546101/image_1472546101.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BSX",
                "summary": "Boston Scientific warns that the cyberattack will hit Q3, but recovery may delay—not lose—revenue. Click here to read this latest analysis of BSX stock.",
                "category": "company",
                "datetime": 1789124256,
                "headline": "Boston Scientific: $43 Finally Prices In A Bad 2026"
              },
              {
                "id": 142067348,
                "url": "https://finnhub.io/api/news?id=dfa5079fce0ec9563cc45107f80904136c80d2ce1641208fd37faf3f76361eb3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) reached $43.1 at the closing of the latest trading day, reflecting a -4.14% change compared to its last close.",
                "category": "company",
                "datetime": 1789077603,
                "headline": "Why Boston Scientific (BSX) Dipped More Than Broader Market Today"
              },
              {
                "id": 142060933,
                "url": "https://finnhub.io/api/news?id=ef33feb7ebdb70b684ce1e068385f2046083c48eadcea26a313690bfe8bd2b6a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
                "category": "company",
                "datetime": 1789044064,
                "headline": "1 of Wall Street’s Favorite Stocks with Promising Prospects and 2 Facing Challenges"
              },
              {
                "id": 142062556,
                "url": "https://finnhub.io/api/news?id=6ffdbe05d27dc47b920fc89735b69b29a5e324c423a0a9938e918775d602e569",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "BSX",
                "summary": "Boston Scientific Corporation (BSX) Wells Fargo 21st Annual Healthcare Conference September 10, 2026 8:00 AM EDTCompany ParticipantsMichael Mahoney -...",
                "category": "company",
                "datetime": 1789043825,
                "headline": "Boston Scientific Corporation (BSX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 142065427,
                "url": "https://finnhub.io/api/news?id=05af60208313dac04e9c83e96027a1516429bde7f125133c85e409fdd09d9883",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Codex-Image-Sep-10--2026--11-14-40-AM.png?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "There are dozens of reasons corporate executives sell shares.\n\n\n\nThey may need money to pay taxes, buy a house, settle a divorce, diversify their wealth, or fund a new boat they will use three times before deciding they",
                "category": "company",
                "datetime": 1789042565,
                "headline": "Alpha Buying: 4 Falling Knives Insiders Are Buying"
              },
              {
                "id": 142065428,
                "url": "https://finnhub.io/api/news?id=d44eb8aaf0536919f7c31235a566b05e4e60a89f0df4c8ad3f5cec2b49de825a",
                "image": "",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "https://event.summitcast.com/view/aMepMFxWv3z5SRZ9meKJzp/PR377yhtGDwnuWjurFvZmp",
                "category": "company",
                "datetime": 1789029698,
                "headline": "Boston Scientific Exec Says Co. Is Re-Evaluating 2027 Framework In Light Of The Cyber Incident And Will Provide A Preview On October; Co. Is Executing A Significant Restructuring Plan That Will Provide Some Financial Benefit"
              },
              {
                "id": 142028634,
                "url": "https://finnhub.io/api/news?id=80e7de8999e6a41acd61752ba4a09ba315b534d097c582121d26f62ef8d54a24",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Trading near $45 a share, Boston Scientific (BSX) sits roughly 58% below its 52-week peak.  Instead of buying the dip outright, selling cash-secured put options allows investors to generate immediate income while locking in an even deeper entry point.  Sell a put option on BSX expiring 9/17/2027, with a strike price of $30.",
                "category": "company",
                "datetime": 1788977210,
                "headline": "BSX Stock: Is It Time To Buy Or Sell Puts?"
              },
              {
                "id": 142026098,
                "url": "https://finnhub.io/api/news?id=7d3c9227baa1161e28f8f9d8a743895fabbc14a68d63e0c57fb3dcc331fbdfc1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 25.7% over the past six months while the S&P 500 was up 13.6%.",
                "category": "company",
                "datetime": 1788964478,
                "headline": "2 Healthcare Stocks with Competitive Advantages and 1 We Question"
              },
              {
                "id": 142024788,
                "url": "https://finnhub.io/api/news?id=c22212c230336e7c168ad8b7cfeef4584b4bdc0b125257cd65ce01367ac9b7ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "MDT lifts its 2027 outlook as broad-based growth accelerates, but margin pressure and competition could test momentum.",
                "category": "company",
                "datetime": 1788959520,
                "headline": "Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum"
              },
              {
                "id": 142026692,
                "url": "https://finnhub.io/api/news?id=f257c60e0ac838bbabd3b08e2bcaf481ecc567336fa28051fd68ad5c9838e20e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/09/Operations-Research-Analysts.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.",
                "category": "company",
                "datetime": 1788944682,
                "headline": "Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday"
              },
              {
                "id": 142030467,
                "url": "https://finnhub.io/api/news?id=9de35833b93f35ae786ccee3dd9929dec0963aed6679925e5b58f3b82570360a",
                "image": "",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "BTIG  analyst Marie Thibault   maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $56.",
                "category": "company",
                "datetime": 1788938561,
                "headline": "BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $56"
              },
              {
                "id": 141953937,
                "url": "https://finnhub.io/api/news?id=3e9048d0135534c7935d3361cef1ae001506389879a9612a9866360c2aea19cd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Healthcare stocks declined late Tuesday afternoon with the NYSE Healthcare Index falling 2.5% and th",
                "category": "company",
                "datetime": 1788896939,
                "headline": "Sector Update: Healthcare Stocks Fall Late Afternoon"
              },
              {
                "id": 141953454,
                "url": "https://finnhub.io/api/news?id=a0495480b7db5648533b280a3e20a0e5458966f2076ed7b7baa4a954890ced83",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Stay updated with the movements of the S&P500 index one hour before the close of the markets on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1788894301,
                "headline": "Uncover the latest developments among S&P500 stocks in today's session."
              },
              {
                "id": 141952718,
                "url": "https://finnhub.io/api/news?id=87d2ee96adbf7ab04fc7d528791a13e1b28a7e0cc48266463d9b072b790eb48a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) flagged its inability to meet its near-term financial outlooks amid a \"mater",
                "category": "company",
                "datetime": 1788889558,
                "headline": "Boston Scientific Flags Guidance Miss Amid 'Material Impact' From Cybersecurity Incident; Shares Fall"
              },
              {
                "id": 141952719,
                "url": "https://finnhub.io/api/news?id=c45670cd3ed49c2b45c8f70c71646e0b65fb45c8b0f42d90ba4eef7ef7fe72a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The medical device maker said it is unlikely to meet its full-year sales growth and adjusted earnings targets, and will update investors on Oct. 28",
                "category": "company",
                "datetime": 1788889254,
                "headline": "Boston Scientific misses 2026 guidance after cyberattack"
              },
              {
                "id": 141952720,
                "url": "https://finnhub.io/api/news?id=c416db3ce32164b10a64d15ac7d9910517120de28674db4d2131662232eda5bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index falling 2.4% and the St",
                "category": "company",
                "datetime": 1788888933,
                "headline": "Sector Update: Healthcare Stocks Fall Tuesday Afternoon"
              },
              {
                "id": 141952721,
                "url": "https://finnhub.io/api/news?id=a19824505e870dd28054eb5b0661495571527ef5f1fa732baf6e42d5e63ddffd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific expects to provide updated full-year 2026 guidance along with its third-quarter results on Oct. 28, 2026.",
                "category": "company",
                "datetime": 1788887887,
                "headline": "Boston Scientific Says Cyberattack Will Impact 2026 Results — Says It Is ‘Unlikely’ To Meet Net Sales Growth, EPS Guidance Ranges"
              },
              {
                "id": 141950050,
                "url": "https://finnhub.io/api/news?id=204594df6a306d6a97d4a8c86c9c90368908bf97c2bc08121e2c01757809b2b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "On this episode of Stock Movers: - Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year. - Intel (INTC) is rising on a report that the company could raise computer chip prices next month.",
                "category": "company",
                "datetime": 1788877550,
                "headline": "Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers"
              },
              {
                "id": 141950901,
                "url": "https://finnhub.io/api/news?id=0cae57435796f0e5ad1b73d7a1fadccdaa9307dc4823ded2e1977f4c9bac3379",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific stock falls as the medical device maker says a recent cyberattack may make it hard to hit quarterly and full-year guidance targets.",
                "category": "company",
                "datetime": 1788875580,
                "headline": "Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls."
              },
              {
                "id": 141950902,
                "url": "https://finnhub.io/api/news?id=0eabaaf388c5ad866673f9ed0120a5a84fa55a3b021885b405c7588e7260f30a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific said Tuesday a cybersecurity incident is likely to have a material impact on its third-quarter and full-year results.",
                "category": "company",
                "datetime": 1788875546,
                "headline": "Boston Scientific Slammed After Cyberattack Hamstrings Sales, Profit"
              },
              {
                "id": 141954408,
                "url": "https://finnhub.io/api/news?id=79179f2d68983dc320d3952f171127c0c567d2ecf5c6c15aad254421e39bb4ba",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/08/Sep-16--2019-Fremont--Ca--Usa---Boston.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "Boston Scientific expects a 2026 earnings miss after a cyberattack disrupted global operations. Manufacturing and shipping are recovering.",
                "category": "company",
                "datetime": 1788873464,
                "headline": "Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack"
              },
              {
                "id": 141950453,
                "url": "https://finnhub.io/api/news?id=eebe68309f481a94b6934beeec3b21104e6e6c4bd2a4817137bc5d1a89a7f42c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "MDT's stronger growth and earnings outlook improve its case, but margin, currency and execution risks keep investors selective.",
                "category": "company",
                "datetime": 1788872280,
                "headline": "Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated?"
              },
              {
                "id": 141950454,
                "url": "https://finnhub.io/api/news?id=0548fb546d0ce08774ad0e3538c5ad806ff32a2d2879291474e269266f92a246",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "BSX's 2026 outlook weakens as WATCHMAN and EP face pressure, but seven launches and cost savings are likely to fuel recovery by 2028.",
                "category": "company",
                "datetime": 1788872100,
                "headline": "Boston Scientific's 2026 Growth Outlook Weakens: Is Recovery Ahead?"
              },
              {
                "id": 141949006,
                "url": "https://finnhub.io/api/news?id=00df6df6df67101935570b3d09b4f6fb117c7f4bf5fcbd493dfc9d008f76108f",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session.",
                "category": "company",
                "datetime": 1788870900,
                "headline": "These S&P500 stocks are moving in today's pre-market session"
              },
              {
                "id": 141950903,
                "url": "https://finnhub.io/api/news?id=5bbc4f11f208f28eb5ad001996d17b2882919a38146bf1c6ed2a757221c2c358",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Despite making progress restoring global operations, the device maker said in a securities filing that it is unlikely to meet third-quarter and full-year sales and earnings forecasts.",
                "category": "company",
                "datetime": 1788867840,
                "headline": "Boston Scientific unlikely to meet guidance due to cyberattack"
              },
              {
                "id": 141950904,
                "url": "https://finnhub.io/api/news?id=478575fefb43cc91c1134a3c2baad3dd9603d7126120060ba66a2284fab2dd2b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) identified a cybersecurity incident affecting certain information technology",
                "category": "company",
                "datetime": 1788866164,
                "headline": "Boston Scientific Unlikely to Meet Net Sales Guidance as Cybersecurity Incident Disrupts Operations"
              },
              {
                "id": 141950905,
                "url": "https://finnhub.io/api/news?id=c1fa882cbb3be0d72012149f1d2f24492079a9dcabe79b684a8afb76d755aa4a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific said it likely won’t meet its financial guidance due to the cyberattack that has disrupted its operations, sending shares of the medical-technology company down sharply in premarket trading.",
                "category": "company",
                "datetime": 1788865080,
                "headline": "Boston Scientific Won’t Meet Guidance Due to Cyberattack"
              },
              {
                "id": 141928274,
                "url": "https://finnhub.io/api/news?id=c5a80caa189b657793fcef789ec8bf9080836371e24927be69f45031c7ae3b48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston was hit by a cyberattack on 25 August that caused widespread disruption to its global operations.",
                "category": "company",
                "datetime": 1788860338,
                "headline": "Boston Scientific on road to recovery following cyberattack"
              },
              {
                "id": 141952234,
                "url": "https://finnhub.io/api/news?id=327359530498b0ed2377041e02882af2b26839ec2e19c09823e4ceb4a73e5e48",
                "image": "https://image.cnbcfm.com/api/v1/image/108222317-1762435648172-gettyimages-2238075663-PELOTON_PRODUCTS.jpeg?v=1778073972&w=1920&h=1080",
                "source": "CNBC",
                "related": "BSX",
                "summary": "These are the stocks posting the largest moves premarket.",
                "category": "company",
                "datetime": 1788851598,
                "headline": "Stocks making the biggest moves premarket: Peloton Interactive, Roivant Sciences, Boston Scientific & more"
              },
              {
                "id": 141954409,
                "url": "https://finnhub.io/api/news?id=b1a9dc6bc2707db4368a377f1fb6364da832f97ec5e87fa59a4e58803d86c8c4",
                "image": "",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "Based on the information currently available as of the date of this Current Report on Form 8-K, the Company has determined that the incident is likely to have a material impact on the Company’s results of operations for",
                "category": "company",
                "datetime": 1788848649,
                "headline": "Boston Scientific Discloses Its Unlikely To Meet Its FY26 And Q3 Adj EPS And Net Sales Growth Guidance After Cybersecurity Incident"
              },
              {
                "id": 141765193,
                "url": "https://finnhub.io/api/news?id=30f82c3d71c728c02b8284a8860ea904bbbc22691e7920cba19df99641cdfb6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Intuitive Surgical's Ion platform is gaining momentum, with rising procedures, a larger installed base and global expansion fueling a second growth engine.",
                "category": "company",
                "datetime": 1788796260,
                "headline": "ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine"
              },
              {
                "id": 141455029,
                "url": "https://finnhub.io/api/news?id=9980113490b89d23a66c8ffb6cd96ecfaacbd42b6a644618293f4755fb4708bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term ~6% growth leaves our 10.8% three-year CAGR reliant on a post-2026 pipeline re-acceleration.",
                "category": "company",
                "datetime": 1788546339,
                "headline": "How Much Upside Can BSX Stock's Growth Deliver?"
              },
              {
                "id": 141437831,
                "url": "https://finnhub.io/api/news?id=00e92f371d6e988ca4bd8fe94b0fb3a9be741d74f0e36ca5ae35fd44bc8650f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.",
                "category": "company",
                "datetime": 1788534720,
                "headline": "Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?"
              },
              {
                "id": 141437622,
                "url": "https://finnhub.io/api/news?id=b8be0d1796ec27cd587c8ff457009a5f9f1b699de6e93f7019af2c890c63a139",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "BSX's ICVT sales have jumped 15% as coronary therapies gained traction, while new devices and deals could extend its growth momentum.",
                "category": "company",
                "datetime": 1788532020,
                "headline": "Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue?"
              },
              {
                "id": 141470804,
                "url": "https://finnhub.io/api/news?id=4595326a6a8093c576238d4fffe33477d69e8468b34008143ded118f32a14fc0",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/04/Sep-16--2019-Fremont--Ca--Usa---Boston.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "Boston Scientific recalls Infinion CX SCS leads following 1,081 injury reports. Health authorities urge immediate return of unused inventory.",
                "category": "company",
                "datetime": 1788525830,
                "headline": "Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk"
              },
              {
                "id": 141437829,
                "url": "https://finnhub.io/api/news?id=ab5a803f9fdec9632073552d65b882523d850dc2da683d48b2074c92f72a3cba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The company is working through a backlog after the cyberattack hampered manufacturing, order processing and shipping.",
                "category": "company",
                "datetime": 1788521400,
                "headline": "Boston Scientific begins to restore shipping after cyberattack"
              },
              {
                "id": 141425819,
                "url": "https://finnhub.io/api/news?id=16e0a7c13c94a2bda9b72b3dce557a34e74dde795511a5550e58651cec3baa9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "In recent weeks, Boston Scientific has faced multiple voluntary global recalls of its Suture Cinch endoscopic devices and ENROUTE Transcarotid Neuroprotection systems, alongside a cybersecurity incident that disrupted operations and led to reduced full‑year 2026 sales and earnings guidance. These simultaneous product quality issues, operational disruptions, and softer demand for key franchises raise fresh questions about the resilience of Boston Scientific’s previously growth-focused...",
                "category": "company",
                "datetime": 1788513680,
                "headline": "Did Recalls And Cyberattack Disruptions Just Shift Boston Scientific's (BSX) Investment Narrative?"
              },
              {
                "id": 141406366,
                "url": "https://finnhub.io/api/news?id=ac7dcb864c0ad21643873e43ba99970b20ef847f2cfaba6231d7dd5dfc7cee5a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "In the most recent trading session, Boston Scientific (BSX) closed at $46.95, indicating a -2.94% shift from the previous trading day.",
                "category": "company",
                "datetime": 1788472802,
                "headline": "Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors"
              },
              {
                "id": 141404317,
                "url": "https://finnhub.io/api/news?id=12b75245389688b8b71b8fe4f31a39d86266438fc4f3f70fd282d3b0f67a3334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Protolabs (PRLB) CEO and President Suresh Krishna joins Market Domination's Josh Lipton to discuss the Trump administration considering additional semiconductor tariffs and the American reshoring of manufacturing.",
                "category": "company",
                "datetime": 1788470270,
                "headline": "Protolabs CEO sees big impact from US reshoring despite potential tariffs"
              },
              {
                "id": 141405392,
                "url": "https://finnhub.io/api/news?id=40c9286481ec07bd46ba0bc42e6f0da850c84ec44ed07d99e03954f645cdc478",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) is back in focus after a series of voluntary global recalls affecting its ENROUTE Transcarotid Neuroprotection Systems and OverStitch Suture Cinch devices, along with a separate cybersecurity incident that has disrupted operations and lowered 2026 guidance. Against this backdrop of recalls and a cybersecurity disruption, Boston Scientific’s recent share price performance has weakened. The stock is at US$48.37 with a year-to-date share price decline of 48.93%, alongside...",
                "category": "company",
                "datetime": 1788469771,
                "headline": "Boston Scientific (BSX) Could Be 23% Undervalued After Recalls And Cyber Incident"
              },
              {
                "id": 141403523,
                "url": "https://finnhub.io/api/news?id=1bb1adddd9848981c1ec4238462275e64b89e0340003f691f5242cca88dfc968",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.",
                "category": "company",
                "datetime": 1788462301,
                "headline": "Thursday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 141403865,
                "url": "https://finnhub.io/api/news?id=9cd5058399002add8c16f829d615ea94956b7a7e1135a345ee6d9ecd3e2a37ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "TransMedics' rapid revenue growth and cheaper valuation face rising margin pressure as heavy investment raises execution risks.",
                "category": "company",
                "datetime": 1788458400,
                "headline": "Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?"
              },
              {
                "id": 141401906,
                "url": "https://finnhub.io/api/news?id=f3dc5631ae476c7b0737759e0d6ea03710eaba62798cf7c6fe5ec2aca8d14af3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (NYSE: BSX) has initiated multiple worldwide product recalls, including a Class I recall of its ENROUTE Transcarotid Neuroprotection System due to risks of arterial sheath tip separation. The company has also begun Class II recalls of certain OverStitch Suture Cinch endoscopic devices, citing deployment and suture cutting failures. These recalls affect widely distributed products and introduce added operational, regulatory and reputational pressures for Boston Scientific in...",
                "category": "company",
                "datetime": 1788455787,
                "headline": "Boston Scientific (BSX) Issues Multiple Worldwide Product Recalls"
              },
              {
                "id": 141404160,
                "url": "https://finnhub.io/api/news?id=1d7681370c9332398aa4a30ebaee3702578ebefede1deaf2fd0a5ed6649fc684",
                "image": "",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/spinal-cord-stimulator-recall-boston-scientific-removes-infinion-cx-lead",
                "category": "company",
                "datetime": 1788445747,
                "headline": "FDA Says Aware Boston Scientific Issued Letter To Affected Customers Recommending Unused Infinion CX Leads Be Removed From Where They Are Used/Sold; As Of May 27, 2026, Boston Scientific Reported 1,081 Serious Injuries And No Deaths Associated With Issue Related To Infinion CX Leads"
              },
              {
                "id": 141400546,
                "url": "https://finnhub.io/api/news?id=3a18202ee756566c59435db8336bbec2549700d31ba7a34cfc5498fb631fc6a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific stock has had a steep year, with a sharp share price decline set against valuation checks that point to a potentially cheap entry point based on intrinsic value and market multiples. The stock now screens as undervalued on both a Discounted Cash Flow (DCF) view and on broader valuation metrics, which raises questions about how much of the recent operational setbacks the market has already priced in. Over the past 12 months, Boston Scientific shares have fallen about 55%,...",
                "category": "company",
                "datetime": 1788444731,
                "headline": "Boston Scientific (BSX) Stock Looks Cheap After a 55% Slump"
              },
              {
                "id": 141398134,
                "url": "https://finnhub.io/api/news?id=315e4e63a13ca58ba3a483d1c034b98269405454a4e5196521d664047bb59b1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific faces a cyberattack, weaker 2026 guidance and business pressures, raising concerns over its outlook and whether investors should exit.",
                "category": "company",
                "datetime": 1788443640,
                "headline": "Cyberattack & Weak 2026 Outlook Weigh on BSX: Is the Stock a Sell?"
              },
              {
                "id": 141381301,
                "url": "https://finnhub.io/api/news?id=6656b7049a2ccee68f115592f96acfe5b77465619173f2ba919bce0c7172dcb4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.",
                "category": "company",
                "datetime": 1788384023,
                "headline": "1 Stock Under $50 to Target This Week and 2 We Ignore"
              },
              {
                "id": 141379530,
                "url": "https://finnhub.io/api/news?id=de9681a0ee09a77cf542eab958e12b5cad3038528e2ac5c18cac277bcda9770e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The market's valuation reflects a wide breadth of potential outcomes for the company, exposing shareholders to the full magnitude of that underlying risk.",
                "category": "company",
                "datetime": 1788375156,
                "headline": "The Wide Divide Priced Into Boston Scientific Stock"
              },
              {
                "id": 141380002,
                "url": "https://finnhub.io/api/news?id=775b7a7617f802b9dc11dd93af8f3697fcec4aa15bfc1b7ccc93b61b46b7238d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific has gotten torched over the last six months - since March 2026, its stock price has dropped 36.9% to $48.10 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1788366263,
                "headline": "2 Reasons to Watch BSX and 1 to Stay Cautious"
              },
              {
                "id": 141381300,
                "url": "https://finnhub.io/api/news?id=fc4696d04061e65f383c549c44f763d63b70d80dd9a4e5b9173bd4d8c2fb2a32",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Despite Boston Scientific’s weak performance relative to its industry peers over the past year, Wall Street analysts remain bullish about the stock’s prospects",
                "category": "company",
                "datetime": 1788359008,
                "headline": "How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks?"
              },
              {
                "id": 141360880,
                "url": "https://finnhub.io/api/news?id=9f26bd8922432f5a0314cbcbab75d980716eaa1f1418c04dae1e6c70cefd2ab9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "This medical device maker posts elite numbers but wears a bargain-bin price tag, and the reason is a sudden crisis of confidence in its star products.",
                "category": "company",
                "datetime": 1788227277,
                "headline": "The Peer-Group Mispricing Sitting On BSX Stock"
              },
              {
                "id": 141360940,
                "url": "https://finnhub.io/api/news?id=036a665dfcf2073c36a6a6f575341e937f13f43edd6e086929670ab6bb25ecb2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "AbbVie, Tandem Diabetes Care and Amgen are targeting aging-related healthcare growth through advances in immunology, diabetes and cardiovascular care.",
                "category": "company",
                "datetime": 1788193740,
                "headline": "Aging Population Drives Healthcare Growth: Stocks to Watch"
              },
              {
                "id": 141363261,
                "url": "https://finnhub.io/api/news?id=4284ccd35f048c06ce669cc44fae7ba737c624ed01ec2ccc81d3bf94f0ae2db1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787934609,
                "headline": "Boston Scientific (BSX) Up 1.5% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141363262,
                "url": "https://finnhub.io/api/news?id=ab1681372a795514cb4a592de777f2b67e528a22bf4e7e285d1126113f8f599a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The attack has affected the company’s ability to manufacture products and to process and ship customers’ orders, and there is still no timeline for restoration.",
                "category": "company",
                "datetime": 1787922300,
                "headline": "Boston Scientific says cyberattack has disrupted product manufacturing"
              },
              {
                "id": 141361639,
                "url": "https://finnhub.io/api/news?id=2a63309d0b9d81e9274876e2e4634aa57f42d6636dcbd71ac15ae9d9a84b49a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Abbott is aiming to capture share from Boston Scientific in the market for devices that seal the heart’s left atrial appendage to reduce stroke risk.",
                "category": "company",
                "datetime": 1787915713,
                "headline": "Abbott wins CE mark for new LAA closure device"
              },
              {
                "id": 141363274,
                "url": "https://finnhub.io/api/news?id=deec6aacae15300f496ed5ab3479e4a295f3d082b05f6de71584ecb6c0dd4976",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "AU, APTV and BSX have been added to the Zacks Rank #5 (Strong Sell) List on August 28th, 2026.",
                "category": "company",
                "datetime": 1787905680,
                "headline": "New Strong Sell Stocks for August 28th"
              },
              {
                "id": 141361650,
                "url": "https://finnhub.io/api/news?id=9d48bf108baf3cbf621771e0479bfd36e732a64ca11aeee9d74c79082830da73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "U.S. electrophysiology growth slowed sharply and standalone WATCHMAN referrals declined in the same window, leaving the rest of Boston Scientific unable to maintain its growth-stock multiple.",
                "category": "company",
                "datetime": 1787851753,
                "headline": "Has BSX Stock Fallen Far Enough To Buy?"
              },
              {
                "id": 141362218,
                "url": "https://finnhub.io/api/news?id=5a0f62b765587d6a8254ffe6e1ff64c712262915d03d08ac141abeef0e7216c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 24.9% gain over the past six months, beating the S&P 500 by 13.3 percentage points.",
                "category": "company",
                "datetime": 1787848627,
                "headline": "3 Healthcare Stocks with Promising Prospects"
              },
              {
                "id": 141362212,
                "url": "https://finnhub.io/api/news?id=9720da8466ecfc8b6ff7afbc2b1c70e58900d268ba6da0019eece70457e63a0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "ISRG's record cash flow is fueling R&D, manufacturing expansion and over 100 da Vinci 5 updates, strengthening its innovation edge.",
                "category": "company",
                "datetime": 1787846220,
                "headline": "Intuitive Surgical's Record Cash Flow Gives It an Innovation Advantage"
              },
              {
                "id": 141363263,
                "url": "https://finnhub.io/api/news?id=6ca00fc93b5862a9e2f4eb5d91e302688ee14c0cc7b0279b43590c8e98e775b6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "The cyberattack on Boston’s IT systems was identified on 25 August and has resulted in a global disruption to the company’s operations.",
                "category": "company",
                "datetime": 1787831598,
                "headline": "Boston Scientific impacted by ongoing cyberattack"
              },
              {
                "id": 141329428,
                "url": "https://finnhub.io/api/news?id=b1fc597f0385a43d7245d505e1d85948a19b49c62e87d9067b4849f39df6a3f3",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Boston Scientific passes the Caviar Cruise quality screen with strong ROIC, cash conversion, and attractive valuation.",
                "category": "company",
                "datetime": 1787831475,
                "headline": "Boston Scientific (NYSE:BSX) Stands Out as a Quality Investment"
              },
              {
                "id": 141363264,
                "url": "https://finnhub.io/api/news?id=911c48ecc352bbddb228e2f002c1048a67034be837bb34c74159dc2a45c01445",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (NYSE: BSX) reports a major cyberattack that is disrupting global operations and access to key IT systems. The company says the incident is impairing its ability to process customer orders worldwide and is still ongoing. Boston Scientific has activated its incident response protocol and is working to restore affected systems. Consider broadening your watchlist to other healthcare and medical technology stocks through 40 healthcare AI stocks. NYSE:BSX 1-Year Stock Price...",
                "category": "company",
                "datetime": 1787829366,
                "headline": "Boston Scientific (BSX) Cyberattack Disrupts Global Orders And Key IT Systems"
              },
              {
                "id": 141363265,
                "url": "https://finnhub.io/api/news?id=66374fef098d8c0ba15656b9c4d0c685231874081f20e35c34cdbd0908bf62b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.",
                "category": "company",
                "datetime": 1787783498,
                "headline": "Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall"
              },
              {
                "id": 141362440,
                "url": "https://finnhub.io/api/news?id=192ef402781a0bd871c18cf063863d3e63fa0683ee6ed400e7b7bad82f4f2638",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific stock crumbled Wednesday after the company said a cybersecurity incident interrupted processing and shipping.",
                "category": "company",
                "datetime": 1787778210,
                "headline": "Boston Scientific Hammered After Cyberattack Tampers With Shipments"
              },
              {
                "id": 141362447,
                "url": "https://finnhub.io/api/news?id=484896653bda1e33aa9eee763cb7174ea64c0aa188ed308c9504b6da583e96d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "For long-suffering owners of Boston Scientific, here’s how to get paid a meaningful cash income now, yours to keep no matter what, in exchange for capping your gains at a higher price.",
                "category": "company",
                "datetime": 1787777512,
                "headline": "Time To Squeeze 14% Yield Out Of Battered BSX Stock?"
              },
              {
                "id": 141363268,
                "url": "https://finnhub.io/api/news?id=9f22b7a95a8facca4466cf57e69e89c82bd16ab1c86c6f3c374a851a9bcf675d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific shares lost ground Wednesday after the company disclosed a cyberattack that caused global disruptions to its operations.",
                "category": "company",
                "datetime": 1787775337,
                "headline": "Boston Scientific Stock Slides After Cyberattack Caused ‘Global Disruption’"
              },
              {
                "id": 141331352,
                "url": "https://finnhub.io/api/news?id=9376c2e75700e2c09d51e4318739596753fabf48eaa5e6f15d6962c58ed80139",
                "image": "https://image.cnbcfm.com/api/v1/image/107417949-1716311561246-gettyimages-2153225565-avdmay24fuji1f.jpeg?v=1718640335&w=1920&h=1080",
                "source": "CNBC",
                "related": "BSX",
                "summary": "The S&P 500 closed Wednesday not too far from where it began as investors waited for Nvidia to post its results. The chipmaker's stock was higher after hours.",
                "category": "company",
                "datetime": 1787772165,
                "headline": "Thursday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 141324624,
                "url": "https://finnhub.io/api/news?id=4fcee419bb1380be82bafd38daa6f2c25af915bc8e8c463bd2166be88758354d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1787771101,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 141324202,
                "url": "https://finnhub.io/api/news?id=c710f4da94ba6b1816de5555e8b2151446aae51f52ce20fa254d5a2921bdc8fd",
                "image": "https://www.chartmill.com/images/uploads/CM_Most_Active_Stocks_Small_free_fec0650b7f.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Stay informed about the most active stocks in the S&P500 index on Wednesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.",
                "category": "company",
                "datetime": 1787767501,
                "headline": "Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session."
              },
              {
                "id": 141323161,
                "url": "https://finnhub.io/api/news?id=3932a9fae53338a86b9c1755b52a37a1e4c996bff7348088d28805b5d2d417b7",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Let's have a look at the S&P500 gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1787754901,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 141331512,
                "url": "https://finnhub.io/api/news?id=c35890bae67d9b866b58823657c8c0b6b3f049c4030693093997cedc693f7915",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/26/Cyber-Threat-Warning-With-Red-Alert-Icon.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "Boston Scientific reports a cyber incident disrupting global operations, limiting system access and affecting order processing and shipments.",
                "category": "company",
                "datetime": 1787753822,
                "headline": "Boston Scientific Reports Global Disruption After Cybersecurity Incident"
              },
              {
                "id": 141323960,
                "url": "https://finnhub.io/api/news?id=cf087cbfcf6442c6f145fa7516f2c7ae3657b296cc038e226f8f91a561b7c4f8",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/26/Stocks-Fall--Technology-Businesses-Do-No.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. Energy leads, gold sinks 1.3% to $4,599.",
                "category": "company",
                "datetime": 1787749114,
                "headline": "Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market Today"
              },
              {
                "id": 141322666,
                "url": "https://finnhub.io/api/news?id=45404df3aec94c43e0fe19f8dea362f33c12ae578f30b5581f5f7c0ff85b82d6",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Get insights into the top gainers and losers in the S&P500 index of Wednesday's pre-market session.",
                "category": "company",
                "datetime": 1787747701,
                "headline": "Top S&P500 movers in Wednesday's pre-market session"
              },
              {
                "id": 141322550,
                "url": "https://finnhub.io/api/news?id=31b2b3975bc89e7f670cfccb0d49754c5ac00d03e98606151a069c9cb7384b1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Opportunities center on pulsed field ablation, advanced mapping catheters and LAAC implants, driven by aging populations and demand for safer, drug-free care. Asia-Pacific expansion, ambulatory procedures, improving reimbursement and regulatory support offer further growth. Atrial Fibrillation Treatment Devices Market Atrial Fibrillation Treatment Devices Market Dublin, Aug. 26, 2026 (GLOBE NEWSWIRE) -- The \"Atrial Fibrillation Treatment Devices Market by Type of Device, Type of Technology, End",
                "category": "company",
                "datetime": 1787745420,
                "headline": "Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic"
              },
              {
                "id": 141322552,
                "url": "https://finnhub.io/api/news?id=bf86c33b693c0919cfc1b2495ad57c2f8ca7d117ffff0eb633d61a93cef7ffde",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific (NYSE:BSX) disclosed on Tuesday that a cybersecurity incident has affected some of its information technology systems, disrupting parts of the medical device company’s operations. Shares of Boston Scientific fell 4% in premarket trading on Wednesday following the disclosure.",
                "category": "company",
                "datetime": 1787740057,
                "headline": "Boston Scientific shares fall after cybersecurity incident disrupts operations"
              },
              {
                "id": 141324053,
                "url": "https://finnhub.io/api/news?id=321e71fa2f7e789e42b4e5e2cf5a045cab6283bfd1a1b7104744cfc11e82e2e6",
                "image": "https://image.cnbcfm.com/api/v1/image/108176392-1753366011605-gettyimages-94822102-pdir0505Hi_j0094JPG.jpeg?v=1787755081&w=1920&h=1080",
                "source": "CNBC",
                "related": "BSX",
                "summary": "The attack has disrupted the company's ability to ship products, and it's not clear when services will be restored.",
                "category": "company",
                "datetime": 1787730447,
                "headline": "Medical device maker Boston Scientific is being hit by a cyberattack. The shares are falling"
              },
              {
                "id": 141323103,
                "url": "https://finnhub.io/api/news?id=67b524777a438472ca04e23732ec972afa1f29c78be45d655329424a4704e42d",
                "image": "",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "On August 25, 2026, Boston Scientific Corporation (the "Company") identified a cybersecurity incident affecting certain of its information technology systems that has resulted in a global disruption to the",
                "category": "company",
                "datetime": 1787724688,
                "headline": "Boston Scientific Discloses Cybersecurity Threat Resulting In Disruption To Global Operations; Investigation Is Ongoing"
              },
              {
                "id": 141322555,
                "url": "https://finnhub.io/api/news?id=fbc0fbca0d6d10fe9adb87c1b803cba253c534273106bbab742332765ee76728",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific is back on familiar ground, but the business arriving this time is not the same. Will a history of strong bounces matter more than a future of weaker growth.",
                "category": "company",
                "datetime": 1787673937,
                "headline": "The Floor Under BSX Stock Is Being Tested Again"
              },
              {
                "id": 141322556,
                "url": "https://finnhub.io/api/news?id=3f84725284617aa33125285cc9195164dc3834fc5613c3ec93dd45dc3f2f94b8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Valuation is improving for Teleflex, but slower Vascular Intervention integration and margin pressure keep execution risks in focus.",
                "category": "company",
                "datetime": 1787664960,
                "headline": "Is TFX a Buy Now as Valuation Improves but Execution Risks Remain?"
              },
              {
                "id": 141317572,
                "url": "https://finnhub.io/api/news?id=05fe13efd00b832cb05a9e82c7065b3ff442b549f68844f834dfbd8fc2100eea",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1787664917,
                "headline": "10 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 141317573,
                "url": "https://finnhub.io/api/news?id=7df4623d35f7f31e57018b603727f6ed315299542ec7d81d04ebef7b27e07f1d",
                "image": "",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "TD Cowen  analyst Joshua Jennings   reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $56 price target.",
                "category": "company",
                "datetime": 1787651526,
                "headline": "TD Cowen Reiterates Buy on Boston Scientific, Maintains $56 Price Target"
              },
              {
                "id": 141322557,
                "url": "https://finnhub.io/api/news?id=ff56634db5317abb95e18b93a89952ee6998653d0a87dd522fc8c4dfaac0b6e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broaden its mix, but its premium valuation raises the execution bar.",
                "category": "company",
                "datetime": 1787596020,
                "headline": "Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?"
              },
              {
                "id": 141322558,
                "url": "https://finnhub.io/api/news?id=58e37c4ac76889dda3d3b52071b6e592ae6a9855fd696e5c0148961bf34f6d79",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Merit Medical's 22.2% monthly rally gains support from stronger Q2 growth and a raised 2026 outlook, but valuation and tariff risks remain.",
                "category": "company",
                "datetime": 1787595900,
                "headline": "Can MMSI Sustain Its 22.2% Gain in the Past Month as Growth Improves?"
              },
              {
                "id": 141322560,
                "url": "https://finnhub.io/api/news?id=8709dc095ddd161daa91d3a51dbfe911ac63dd53a225916c372e4403e7ec998d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "TFX's $1.5B OEM sale cuts leverage and lifts 2026 EPS guidance, but weaker growth and margin pressure keep the outlook measured.",
                "category": "company",
                "datetime": 1787577960,
                "headline": "Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?"
              },
              {
                "id": 141280539,
                "url": "https://finnhub.io/api/news?id=a8869bfa7e8b3a15dfb45b62c9c05fe9ff3e2503d10feaf83d0413bf7c76be07",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Its capital budget has overtaken its research budget for the first time in the fifteen years on record, and two of the seven launches management is counting on to restore growth come from outside its own labs.",
                "category": "company",
                "datetime": 1787341523,
                "headline": "Are You Still Holding Boston Scientific Stock For Its Next Device?"
              },
              {
                "id": 141265068,
                "url": "https://finnhub.io/api/news?id=93f337f985f0311e22819a35e71c4675f54bf694bae3c2e6449779c783ab45d3",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2190656202/image_2190656202.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BSX",
                "summary": "Michael Kramer from Reading The Markets shares why it's important to understand market direction, implied volatility and option positioning.",
                "category": "company",
                "datetime": 1787247900,
                "headline": "Hedging Exposure In This Volatile Market"
              },
              {
                "id": 141280550,
                "url": "https://finnhub.io/api/news?id=5e905aed6a31a32566b37857da91b4503090edcac1c293779bc5b16da3174236",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 14.69% in the second quarter of 2026, slightly trailing the 15.20% gain of the S&P 500 Index as market performance remained highly concentrated in artificial intelligence (AI)-related […]",
                "category": "company",
                "datetime": 1786999703,
                "headline": "Boston Scientific (BSX) Faces Growth Concerns in Key Medical Device Franchises"
              },
              {
                "id": 141241353,
                "url": "https://finnhub.io/api/news?id=5cab7b64c6cb8a72df1dc0efe8e960408190bd0370051d4d03bf5fa7cdf53c87",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BSX",
                "summary": "Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.54% on an annualized basis producing an average annual return of 15.01%. Currently, Boston Scientific has a market capitalization of",
                "category": "company",
                "datetime": 1786964464,
                "headline": "If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today"
              },
              {
                "id": 141226752,
                "url": "https://finnhub.io/api/news?id=195ffcf841a4fdcaf6d5cebab2fc8c58b2a5d070c8f44d4fb9688334ada279a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific completes multi year buyback and what it means for investors Boston Scientific (BSX) has completed a multi year share repurchase program, buying back 39,922,436 shares for about US$2.0b. The completed buyback represents 2.69% of the company’s shares. This update provides an additional data point on how Boston Scientific is allocating capital and managing its share count. It also offers a clearer backdrop for assessing recent stock performance and earnings expectations. See...",
                "category": "company",
                "datetime": 1786770483,
                "headline": "Boston Scientific (BSX), What Is Behind The Latest Investor Attention?"
              },
              {
                "id": 141226753,
                "url": "https://finnhub.io/api/news?id=4621fb65a45c2a5eba53503487e46440203bebae0adb9720ab7a849f5846763d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "In the June quarter, Boston Scientific completed a share repurchase of 39,922,436 shares, equal to 2.69% of its stock, for US$2,000.11 million under the buyback first announced in December 2020, while quarterly results highlighted underperformance in U.S. Electrophysiology and Watchman alongside lower 2026 organic sales growth guidance. Although the CHAMPION-AF trial met all clinical endpoints, it did not act as a meaningful catalyst for the business outlook, and the contrast between bullish...",
                "category": "company",
                "datetime": 1786763879,
                "headline": "Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance?"
              },
              {
                "id": 141226754,
                "url": "https://finnhub.io/api/news?id=335f07356fadea9e75b71e544f82b09afccbb5f9f384f4e075463e6b62b86f4c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Boston Scientific stock has fallen about 50% over the past year, yet valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both suggest the shares may be trading below what the fundamentals imply. That gap between weak recent returns and an undervalued read is now front of mind for anyone looking at the current US$51.83 share price. Over the last 12 months, Boston Scientific has declined 49.8%, which puts recent investor sentiment and the current...",
                "category": "company",
                "datetime": 1786745604,
                "headline": "Is Boston Scientific (BSX) Still Undervalued After A 50% Fall?"
              },
              {
                "id": 141226765,
                "url": "https://finnhub.io/api/news?id=944238222c9a941c04cbf9bb360c8aaf00f754e3da0e49ccc10edebf065198f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.",
                "category": "company",
                "datetime": 1786721820,
                "headline": "Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?"
              },
              {
                "id": 141216128,
                "url": "https://finnhub.io/api/news?id=65bf5a20ca49fa677ed91b73d8243709c5f98aa21cfb6e399a4d084fa22e6884",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session.",
                "category": "company",
                "datetime": 1786710901,
                "headline": "Get insights into the top movers in the S&P500 index of Friday's pre-market session."
              },
              {
                "id": 141216725,
                "url": "https://finnhub.io/api/news?id=75b3ea82141ce5c2d9b288a912788b857b5a70b3f29d76f59065d6a21564acbb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1282122168/image_1282122168.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) stock: EP/WATCHMAN slowdown drives discount valuation. See why it’s a Buy—new launches, insider buying, cost savings.",
                "category": "company",
                "datetime": 1786705872,
                "headline": "Boston Scientific: A Deep Dive Into The Headwinds And Why I See A Recovery Ahead"
              },
              {
                "id": 141226755,
                "url": "https://finnhub.io/api/news?id=55433c80e75ebad19a7caab3efa90c342dfe578b4bba7b22720af19821500a42",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” second quarter of 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 16.83% in the second quarter of 2026, outperforming the S&P 500’s 15.20% gain. Performance was supported by holdings in Information Technology and Communication Services, as […]",
                "category": "company",
                "datetime": 1786703082,
                "headline": "Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses"
              },
              {
                "id": 141210844,
                "url": "https://finnhub.io/api/news?id=2bf736f8c82a4e2be8402c591dd67c6328e0044a4c9301341ce2ff92fa7cc5f8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Options price a band whose floor sits below anything the stock has touched in the past year, and the company's own recovery timetable lands after that window closes.",
                "category": "company",
                "datetime": 1786656117,
                "headline": "How Much More Can Boston Scientific Stock Move After Losing Half Its Value?"
              },
              {
                "id": 141206676,
                "url": "https://finnhub.io/api/news?id=7abea3ccfe08377481fd5e0f37f8dec44b691a75bc8a1a729baa8f037ed84ee9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
                "category": "company",
                "datetime": 1786627802,
                "headline": "Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet"
              },
              {
                "id": 141205638,
                "url": "https://finnhub.io/api/news?id=ebfa5769075e97a602a52fd7b83cec2836f85d750cb243af63d561c81837cfec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the ‘TCW Concentrated Large Cap Growth Fund.’ A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve leadership transition were the significant events. All major indices ended higher, […]",
                "category": "company",
                "datetime": 1786626893,
                "headline": "Here’s What Hurt Boston Scientific Corporation (BSX) in Q2"
              },
              {
                "id": 141205611,
                "url": "https://finnhub.io/api/news?id=dd5eca2ade8f4181ead20a9e255e7c1a5afce1573708bd3d80f4816f41e5a7fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "Edwards' 14% three-month rally reflects broad structural-heart growth, but its premium valuation raises the bar for execution.",
                "category": "company",
                "datetime": 1786625460,
                "headline": "Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation"
              },
              {
                "id": 141205552,
                "url": "https://finnhub.io/api/news?id=8d6f1220353ab322d745ae83b3fe05b60386f09680f005e4e5b42c473a87a446",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BSX",
                "summary": "ABT's EPD growth is fueled by emerging-market strength, broad branded generics and healthcare demand, with biosimilars adding opportunities.",
                "category": "company",
                "datetime": 1786625340,
                "headline": "What's Backing Abbott's Established Pharmaceuticals Division Growth"
              },
              {
                "id": 141192503,
                "url": "https://finnhub.io/api/news?id=0114c384af13db6c4685092791adbeee5212fb41eea7679e4dc19a14f358a711",
                "image": "https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp",
                "source": "ChartMill",
                "related": "BSX",
                "summary": "Boston Scientific (BSX) screens as a decent value: cheap vs peers, strong profitability, and solid health, scoring 7/10.",
                "category": "company",
                "datetime": 1786535532,
                "headline": "Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 104,
            "discarded_article_count": 76
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 11.9,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0,
            "vcp_reason": "Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 19544173.333333332,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 18626120,
              "avg_vol_20": 19866005,
              "avg_vol_30": 19544173.333333332,
              "range_pct_10": 0.16007445323406225,
              "range_pct_20": 0.23755234993020014,
              "range_pct_30": 0.23755234993020014,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9530267503426427,
              "dist_to_20d_high": 0.18890356671070022,
              "down_shrink_days": 2,
              "breakout_level_20d": 52.99,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6738491674828594
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.5,
            "details": {
              "atrPct": 4.285946952070731,
              "turnoverUsdM": 1159.11102972,
              "liquidityPoints": 0.8,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.BSX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 39.2958,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 8.6,
            "take_profit_price": 46.7133,
            "target_multiplier": 1.9,
            "technical_strength": 1.6,
            "take_profit_percent": 8.7
          },
          "positionPoints": 1.5,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 8.571893904141461,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.BSX",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 1.8421,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 4.29
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -170.5
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.2637
    },
    "kdj": {
      "d": 16.37,
      "j": -5.08,
      "k": 9.22,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 23.39
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": -18850014,
      "recentSlope": -7697151.4,
      "previousSlope": -3782170
    },
    "rsi": 24.74,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 46.0785,
      "position": "SAR喺價上",
      "distancePct": 7.21,
      "previousTrend": "下降"
    },
    "ma50": 46.9372,
    "macd": {
      "macd": -1.0048126604520675,
      "trend": "看跌",
      "signal": -0.23156963787061374,
      "histogram": -0.7732430225814537
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 48.0441,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.32,
      "score": 6,
      "avgVolume": 20429436,
      "currentVolume": 26968614
    },
    "derived": {
      "ma20": 48.0775,
      "ma50": 46.9372,
      "prevClose": 43.1,
      "avgVolume10": 19695261,
      "avgVolume20": 20429436,
      "changePercent": -0.28,
      "avgVolumeForScore": 20429436
    },
    "ma_cross": {
      "ma20": 48.0775,
      "ma50": 46.9372,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 48.513,
      "prevMa50": 46.9388,
      "spreadPct": 2.43,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 42.9285,
      "upper": 53.2265,
      "position": "中間"
    },
    "rsi_short": 11.99,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.32
    }
  }
}

{
  "close": 42.98,
  "volume": 26968614,
  "changePercent": -0.28
}